Treating heart failure with cardiac contractility modulation electrical signals
Authors:
- Hani N. SabbahHSHani N. Sabbah
- Ramesh C. GuptaRGRamesh C. Gupta
- Sharad RastogiSRSharad Rastogi
- Sudhish MishraSMSudhish Mishra
- Yuval MikaYMYuval Mika
- Daniel BurkhoffDBDaniel Burkhoff
- 1 April 2006
- journal article
- review article
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 3 (1) , 21-24
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Cardiac contractility modulation with non-excitatory electrical signals normalizes expression of the transcriptional factor GATA-4 in dogs with chronic heart failureHeart Rhythm, 2005
- Chronic therapy with non-excitatory cardiac contractility modulation electric signals improves left ventricular function, reduces myocardial oxygen consumption and increases myocardial mechanical efficiencyHeart Rhythm, 2005
- Sarcoplasmic reticulum Ca-ATPase–phospholamban interactions and dilated cardiomyopathyBiochemical and Biophysical Research Communications, 2004
- First Human Chronic Experience with Cardiac Contractility Modulation by Nonexcitatory Electrical Currents for Treating Systolic Heart Failure:Journal of Cardiovascular Electrophysiology, 2004
- ?Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failureEuropean Heart Journal, 2004
- Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart FailureCirculation, 2003
- Pacing in heart failure: improved ventricular interaction in diastole rather than systolic re-synchronizationEP Europace, 2000
- Phospholamban and cardiac contractilityAnnals of Medicine, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Reduced Ca2+-Sensitivity of SERCA 2a in Failing Human Myocardium due to Reduced Serin-16 Phospholamban PhoshorylationJournal of Molecular and Cellular Cardiology, 1999